Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 13,685 Reduced 5.11% |
$2,280,057
$166.61 p/Share
|
Jan 29
2025 |
|
NTRA
|
John Fesko
PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct | 4,030 Reduced 2.74% |
$670,511
$166.38 p/Share
|
Jan 29
2025 |
|
NTRA
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct | 5,201 Reduced 3.7% |
$865,290
$166.37 p/Share
|
Jan 29
2025 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 4,773 Reduced 2.19% |
$793,797
$166.31 p/Share
|
Jan 29
2025 |
|
NTRA
|
Matthew Rabinowitz
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 6,003 Reduced 0.25% |
$1,000,159
$166.61 p/Share
|
Jan 29
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 1,054 Reduced 0.4% |
$175,501
$166.51 p/Share
|
Jan 29
2025 |
|
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 79,118 Reduced 1.37% |
$4,281,074
$54.11 p/Share
|
Jan 29
2025 |
|
ATEC
|
Patrick Miles
CEO |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 0.81% |
$601,500
$12.03 p/Share
|
Jan 29
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 9,907 Reduced 0.09% |
$111,453
$11.25 p/Share
|
Jan 29
2025 |
|
WEAV
|
Blake G Modersitzki |
SELL
Open market or private sale
|
Indirect | 40,907 Reduced 0.0% |
$673,738
$16.47 p/Share
|
Jan 29
2025 |
|
ABT
|
Hubert L Allen
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 131,360 Reduced 41.55% |
$16,860,056
$128.35 p/Share
|
Jan 29
2025 |
|
NPCE
|
Martha Morrell
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.11% |
$1,500
$15.0 p/Share
|
Jan 29
2025 |
|
BENF
|
Jeff Welday
Officer |
SELL
Open market or private sale
|
Direct | 1,199 Reduced 0.79% |
$743
$0.62 p/Share
|
Jan 29
2025 |
|
NTRS
|
Peter Cherecwich
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 26,132 Reduced 49.57% |
$2,936,191
$112.36 p/Share
|
Jan 29
2025 |
|
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 34,798 Reduced 0.0% |
$76,207
$2.19 p/Share
|
Jan 29
2025 |
|
ALK
|
Kyle B Levine
SVP LEGAL & GEN COUNSEL |
SELL
Open market or private sale
|
Direct | 4,333 Reduced 20.59% |
$314,402
$72.56 p/Share
|
Jan 29
2025 |
|
SMFR
|
Katherine Stueland
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,657 Reduced 29.62% |
$130,041
$78.48 p/Share
|
Jan 29
2025 |
|
SMFR
|
Kevin Feeley
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 275 Reduced 8.53% |
$21,582
$78.48 p/Share
|
Jan 29
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Direct | 806 Reduced 0.37% |
$18,135
$22.5 p/Share
|
Jan 29
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Indirect | 603 Reduced 0.0% |
$13,567
$22.5 p/Share
|
Jan 29
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 31,409 Reduced 0.0% |
$2,059,488
$65.57 p/Share
|
Jan 29
2025 |
|
AGBAR
|
Robert E. Diamond Jr. |
SELL
Open market or private sale
|
Indirect | 96,659 Reduced 0.0% |
$190,418
$1.97 p/Share
|
Jan 29
2025 |
|
NXT
|
David P Bennett
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 9,801 Reduced 7.29% |
$489,069
$49.9 p/Share
|
Jan 29
2025 |
|
HBT
|
Fred L Drake
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$243,800
$24.38 p/Share
|
Jan 29
2025 |
|
HIPO
|
Torben Ostergaard
CEO Spinnaker |
SELL
Open market or private sale
|
Direct | 3,022 Reduced 3.07% |
$82,349
$27.25 p/Share
|
Jan 29
2025 |
|
NAMS
|
Douglas F Kling
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 56,863 Reduced 56.38% |
-
|
Jan 29
2025 |
|
SMTC
|
Mark Lin
EVP and CFO |
SELL
Open market or private sale
|
Direct | 2,990 Reduced 35.44% |
$180,117
$60.24 p/Share
|
Jan 29
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 3,836 Reduced 0.0% |
$37,285
$9.72 p/Share
|
Jan 29
2025 |
|
RMED
|
Martin J Colombatto
Director |
SELL
Open market or private sale
|
Indirect | 3 Reduced 0.0% |
$1
$0.4 p/Share
|
Jan 29
2025 |
|
WFRD
|
Scott C Weatherholt
EVP, GC & CCO |
SELL
Open market or private sale
|
Direct | 44,505 Reduced 26.25% |
$2,959,582
$66.5 p/Share
|
Jan 29
2025 |
|
ABEO
|
Mark Alvino
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 5.85% |
$21,520
$5.38 p/Share
|
Jan 29
2025 |
|
CRDO
|
Yat Tung Lam
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 0.0% |
$5,924,000
$59.24 p/Share
|
Jan 29
2025 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.22% |
$14,840
$29.68 p/Share
|
Jan 29
2025 |
|
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 0.0% |
$424,470
$141.49 p/Share
|
Jan 29
2025 |
|
NTLA
|
Muna Bhanji |
SELL
Open market or private sale
|
Direct | 265 Reduced 1.34% |
$2,642
$9.97 p/Share
|
Jan 29
2025 |
|
PLMR
|
Jon Christianson
President |
SELL
Open market or private sale
|
Direct | 478 Reduced 0.84% |
$51,786
$108.34 p/Share
|
Jan 29
2025 |
|
PLMR
|
Jonathan Knutzen
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 379 Reduced 1.91% |
$41,060
$108.34 p/Share
|
Jan 29
2025 |
|
PLMR
|
Angela L. Grant
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 394 Reduced 8.08% |
$42,685
$108.34 p/Share
|
Jan 29
2025 |
|
CNXC
|
Cormac J Twomey
EVP, Global Ops & Delivery |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.2% |
$27,800
$55.6 p/Share
|
Jan 29
2025 |
|
PLMR
|
T Christopher Uchida
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 507 Reduced 2.76% |
$54,928
$108.34 p/Share
|
Jan 29
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$22,860
$11.43 p/Share
|
Jan 29
2025 |
|
PLMR
|
Mac Armstrong
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 2,444 Reduced 3.62% |
$264,782
$108.34 p/Share
|
Jan 29
2025 |
|
WABC
|
Robert James Baker Jr
SVP/Banking Division Manager |
SELL
Open market or private sale
|
Direct | 248 Reduced 16.34% |
$12,836
$51.76 p/Share
|
Jan 29
2025 |
|
VLY
|
Joseph Chillura
SEVP, CML Banking President |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 9.17% |
$510,500
$10.21 p/Share
|
Jan 29
2025 |
|
SNCY
|
John Gyurci
Chief Acct. Off. & VP, Finance |
SELL
Open market or private sale
|
Direct | 200 Reduced 1.69% |
$3,400
$17.0 p/Share
|
Jan 29
2025 |
|
CDR
|
Michael Andrew Franklin
CEO |
SELL
Open market or private sale
|
Direct | 850 Reduced 44.74% |
$13,387
$15.75 p/Share
|
Jan 29
2025 |
|
CPZ
|
Thomas E Herman
VP and CFO |
SELL
Open market or private sale
|
Direct | 13,392 Reduced 50.0% |
$208,647
$15.58 p/Share
|
Jan 29
2025 |
|
VZ
|
Kyle Malady
EVP and Group CEO-VZ Business |
SELL
Open market or private sale
|
Direct | 11,085 Reduced 43.17% |
$453,154
$40.88 p/Share
|
Jan 29
2025 |
|
RLAY
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct | 26,541 Reduced 5.95% |
$120,761
$4.55 p/Share
|
Jan 29
2025 |
|
RLAY
|
Thomas Catinazzo
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,109 Reduced 0.52% |
$9,595
$4.55 p/Share
|
Jan 29
2025 |